MediWound MDWD
NASDAQ MDWD
$13.21 +0.10 (+0.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

MediWound (MDWD) Change in Accured Expenses (2017 - 2025)

MediWound (MDWD) posted quarterly Change in Accured Expenses of -$1.1 million for Q2 2025, down 261.84% year-over-year from $679674.8 in Q2 2024, and down 134.18% quarter-over-quarter from $3.2 million in Q4 2024.

MediWound (MDWD) Change in Accured Expenses (2017 - 2025) Analysis & Trends

MediWound's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$1.1 million for Q2 2025.

  • In Q2 2025, Change in Accured Expenses fell 261.84% year-over-year to -$1.1 million; the TTM figure through Jun 2025 stood at $1.8 million (up 379.43% YoY), while the FY2024 annual figure was $1.3 million, up 313.8% from the prior year.
  • Change in Accured Expenses for Q2 2025 stood at -$1.1 million, down from $3.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.2 million in Q4 2024, with the low at -$2.0 million in Q2 2022.
  • The 5-year median for Change in Accured Expenses is -$49500.0 (2023), against an average of -$137437.5.
  • The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses soared 49600.0% in 2021, then plunged 15637.5% in 2022.
  • MediWound's Change in Accured Expenses stood at $990000.0 in 2021, then slipped by 20.81% to $784000.0 in 2022, then soared by 39.41% to $1.1 million in 2023, then soared by 194.42% to $3.2 million in 2024, then plunged by 134.18% to -$1.1 million in 2025.
  • Business Quant data shows MDWD's Change in Accured Expenses at -$1.1 million in Q2 2025, $3.2 million in Q4 2024, and -$48000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 MediWound 170.65 Mn 139.65 Mn 337,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.10 Mn
Jun 30, 2025 -1.10 Mn
Dec 31, 2024 3.22 Mn
Dec 31, 2024 3.22 Mn
Sep 30, 2024 -48,000.00
Sep 30, 2024 -48,000.00
Jun 30, 2024 -304,000.00
Jun 30, 2024 -304,000.00
Mar 31, 2024 -1.37 Mn
Mar 31, 2024 -1.37 Mn
Dec 31, 2023 1.09 Mn
Dec 31, 2023 1.09 Mn
Sep 30, 2023 -51,000.00
Sep 30, 2023 -51,000.00
Jun 30, 2023 -1.90 Mn
Jun 30, 2023 -1.90 Mn
Mar 31, 2023 -1.95 Mn
Mar 31, 2023 -1.95 Mn
Dec 31, 2022 784,000.00
Dec 31, 2022 784,000.00